Cardiovascular Systems Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $20
- Today's High:
- $20
- Open Price:
- $20
- 52W Low:
- $12.255
- 52W High:
- $20
- Prev. Close:
- $20
- Volume:
- 0
Company Statistics
- Market Cap.:
- $843.96 million
- Book Value:
- 5.704
- Revenue TTM:
- $239.84 million
- Operating Margin TTM:
- -16.08%
- Gross Profit TTM:
- $172.78 million
- Profit Margin:
- -15.79%
- Return on Assets TTM:
- -7.56%
- Return on Equity TTM:
- -15.18%
Company Profile
Cardiovascular Systems Inc had its IPO on 2009-02-26 under the ticker symbol CSII.
The company operates in the Healthcare sector and Medical Devices industry. Cardiovascular Systems Inc has a staff strength of 725 employees.
Stock update
Shares of Cardiovascular Systems Inc opened at $20 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $20 - $20, and closed at $20.
This is a 0% increase from the previous day's closing price.
A total volume of 0 shares were traded at the close of the day’s session.
In the last one week, shares of Cardiovascular Systems Inc have increased by +0.1%.
Cardiovascular Systems Inc's Key Ratios
Cardiovascular Systems Inc has a market cap of $843.96 million, indicating a price to book ratio of 2.4301 and a price to sales ratio of 2.5127.
In the last 12-months Cardiovascular Systems Inc’s revenue was $239.84 million with a gross profit of $172.78 million and an EBITDA of $-33590000. The EBITDA ratio measures Cardiovascular Systems Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Cardiovascular Systems Inc’s operating margin was -16.08% while its return on assets stood at -7.56% with a return of equity of -15.18%.
In Q4, Cardiovascular Systems Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 3.9%.
Cardiovascular Systems Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 177.27
Its diluted EPS in the last 12-months stands at $-0.96 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 177.27. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cardiovascular Systems Inc’s profitability.
Cardiovascular Systems Inc stock is trading at a EV to sales ratio of 1.9624 and a EV to EBITDA ratio of -14.4896. Its price to sales ratio in the trailing 12-months stood at 2.5127.
Cardiovascular Systems Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $311.51 million
- Total Liabilities
- $36.76 million
- Operating Cash Flow
- $-864000.00
- Capital Expenditure
- $2.04 million
- Dividend Payout Ratio
- 0%
Cardiovascular Systems Inc ended 2024 with $311.51 million in total assets and $0 in total liabilities. Its intangible assets were valued at $311.51 million while shareholder equity stood at $239.39 million.
Cardiovascular Systems Inc ended 2024 with $3.37 million in deferred long-term liabilities, $36.76 million in other current liabilities, 40000.00 in common stock, $-443413000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $59.84 million and cash and short-term investments were $132.00 million. The company’s total short-term debt was $0 while long-term debt stood at $0.
Cardiovascular Systems Inc’s total current assets stands at $221.96 million while long-term investments were $42.03 million and short-term investments were $72.16 million. Its net receivables were $40.23 million compared to accounts payable of $17.09 million and inventory worth $41.19 million.
In 2024, Cardiovascular Systems Inc's operating cash flow was $-864000.00 while its capital expenditure stood at $2.04 million.
Comparatively, Cardiovascular Systems Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $20
- 52-Week High
- $20
- 52-Week Low
- $12.255
- Analyst Target Price
- $17.4
Cardiovascular Systems Inc stock is currently trading at $20 per share. It touched a 52-week high of $20 and a 52-week low of $20. Analysts tracking the stock have a 12-month average target price of $17.4.
Its 50-day moving average was $19.83 and 200-day moving average was $15.85 The short ratio stood at 2.66 indicating a short percent outstanding of 0%.
Around 322.7% of the company’s stock are held by insiders while 8964.9% are held by institutions.
Frequently Asked Questions About Cardiovascular Systems Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. As of April 27, 2023, Cardiovascular Systems, Inc. operates as subsidiary of Abbott Laboratories (NYSE:ABT).